Adverse drug reactions in children in China is 2 times as large as that of children-女f4

Our children’s drug adverse reaction rate is 2 times the adult children should use children’s medicine "survey of children’s medication safety in 2016 white paper" released in Beijing on 13 May, the white paper data show that China’s children’s drug adverse reaction rate is 2 times that of adults, children’s medication safety still need to be further strengthened. In the first meeting by the national health plan of child safety medication spread and development sponsored by the Commission on Education Center, the State Food and Drug Administration smeri released the investigation report "2016 white paper" children’s drug safety. The white paper pointed out that China’s huge population base, accounting for nearly 17% of the total population, but less than 2% of child specific medicines, pediatrician gap. According to the national adverse drug reaction monitoring report shows that the adverse reaction of children medication rate is 2 times that of adults, it has not been perfect children development in various organs and the immune system, adverse drug reaction and toxicity of the damage can not be ignored. To solve this problem, the Chinese Academy of Engineering Li Lianda China that crack children’s medicine predicament, need more child specific medicines, need government, science, production and research "linkage, for pharmaceutical companies, hospitals and research institutions to form more benign development interaction mechanism, as a positive, mutual supplement, take the initiative to play. Zhang Feng, deputy director of the National Health Planning Commission Secretary medicine said that the protection of children’s medication work is a complicated system engineering, involved in the service of the population, multi field, long chain. Therefore, in addition to government departments to continue to do the overall planning and design, improve the laws and regulations, improve the security system, but also the need for joint efforts of all sectors of society. Medical institutions and medical personnel to improve pediatric medication and clinical diagnosis and treatment services; drug R & D and production enterprises to continuously enhance the sense of social responsibility, increase children’s drug R & D and production investment, produce more and better and cost-effective drugs for children and related technology products; the public should also set up the good children drug habits and ideas, improve children’s medication safety awareness and level.相关的主题文章: